Characteristics and Prognosis of Patients With Inflammatory Bowel Disease During the SARS-CoV-2 Pandemic in the Basque Country (Spain).
作者信息
Rodríguez-Lago Iago, Ramírez de la Piscina Patricia, Elorza Ainara, Merino Olga, Ortiz de Zárate Jone, Cabriada José Luis
机构信息
Gastroenterology Department, Hospital de Galdakao and Biocruces Bizkaia Health Research Institute, Galdakao, Spain.
Hospital Universitario Araba, Vitoria, Spain.
出版信息
Gastroenterology. 2020 Aug;159(2):781-783. doi: 10.1053/j.gastro.2020.04.043. Epub 2020 Apr 21.
Abstract
摘要
相似文献
1
Characteristics and Prognosis of Patients With Inflammatory Bowel Disease During the SARS-CoV-2 Pandemic in the Basque Country (Spain).西班牙巴斯克地区新冠疫情期间炎症性肠病患者的特征与预后
Gastroenterology. 2020 Aug;159(2):781-783. doi: 10.1053/j.gastro.2020.04.043. Epub 2020 Apr 21.
2
SARS-CoV-2 in Spanish Intensive Care Units: Early experience with 15-day survival in Vitoria.西班牙重症监护病房中的 SARS-CoV-2：维多利亚 15 天生存的早期经验。
Anaesth Crit Care Pain Med. 2020 Oct;39(5):553-561. doi: 10.1016/j.accpm.2020.04.001. Epub 2020 Apr 9.
3
Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry.皮质类固醇，而不是 TNF 拮抗剂，与炎症性肠病患者 COVID-19 不良结局相关：来自国际登记处的结果。
Gastroenterology. 2020 Aug;159(2):481-491.e3. doi: 10.1053/j.gastro.2020.05.032. Epub 2020 May 18.
4
Clinical Characteristics and Outcomes of Coronavirus Disease 2019 Among Patients With Preexisting Liver Disease in the United States: A Multicenter Research Network Study.美国已有肝病患者中2019冠状病毒病的临床特征与转归：一项多中心研究网络研究
Gastroenterology. 2020 Aug;159(2):768-771.e3. doi: 10.1053/j.gastro.2020.04.064. Epub 2020 May 4.
5
Risk of Severe Coronavirus Disease 2019 in Patients With Inflammatory Bowel Disease in the United States: A Multicenter Research Network Study.美国炎症性肠病患者发生重症2019冠状病毒病的风险：一项多中心研究网络研究
Gastroenterology. 2020 Oct;159(4):1575-1578.e4. doi: 10.1053/j.gastro.2020.06.003. Epub 2020 Jun 6.
6
In-ICU COVID-19 patients' characteristics for an estimation in post-ICU rehabilitation care requirement.用于评估重症监护病房后康复护理需求的新冠肺炎重症监护病房患者特征。
Anaesth Crit Care Pain Med. 2020 Aug;39(4):479-480. doi: 10.1016/j.accpm.2020.06.002. Epub 2020 Jun 13.
7
Enteric involvement in hospitalised patients with COVID-19 outside Wuhan.武汉以外地区新冠肺炎住院患者的肠道受累情况。
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):534-535. doi: 10.1016/S2468-1253(20)30118-7. Epub 2020 Apr 15.
8
Intensive care unit acquired muscle weakness in COVID-19 patients.新冠病毒肺炎患者的重症监护病房获得性肌无力
Intensive Care Med. 2020 Nov;46(11):2083-2085. doi: 10.1007/s00134-020-06244-7. Epub 2020 Sep 28.
9
Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State.华盛顿州 21 例 COVID-19 危重症患者的特征和结局。
JAMA. 2020 Apr 28;323(16):1612-1614. doi: 10.1001/jama.2020.4326.
10
Sleep Apnea and COVID-19 Mortality and Hospitalization.睡眠呼吸暂停与新冠病毒疾病的死亡率及住院率
Am J Respir Crit Care Med. 2020 Nov 15;202(10):1462-1464. doi: 10.1164/rccm.202006-2252LE.
引用本文的文献
1
Inflammatory bowel diseases and the clinical course of coronavirus disease 2019 - a Polish single-centre experience from the pre-vaccine era.炎症性肠病与2019冠状病毒病的临床病程——波兰疫苗接种前时代的单中心经验
Prz Gastroenterol. 2023;18(4):409-415. doi: 10.5114/pg.2023.133479. Epub 2023 Dec 8.
2
Symptoms and Severity of COVID-19 in Patients with Immune-Mediated Inflammatory Diseases: Experience of a University Medical Center.免疫介导的炎症性疾病患者中 COVID-19 的症状与严重程度：一所大学医学中心的经验
Autoimmune Dis. 2024 Mar 27;2024:6627035. doi: 10.1155/2024/6627035. eCollection 2024.
3
Preexisting Autoimmunity Is Associated With Increased Severity of Coronavirus Disease 2019: A Retrospective Cohort Study Using Data From the National COVID Cohort Collaborative (N3C).预先存在的自身免疫与 2019 年冠状病毒病严重程度增加相关：使用来自国家 COVID 队列协作（N3C）的数据的回顾性队列研究。
Clin Infect Dis. 2023 Sep 18;77(6):816-826. doi: 10.1093/cid/ciad294.
4
Evaluation of infliximab/tocilizumab versus tocilizumab among COVID-19 patients with cytokine storm syndrome.评估 COVID-19 细胞因子风暴综合征患者中使用英夫利昔单抗/托珠单抗与托珠单抗的效果。
Sci Rep. 2023 Apr 20;13(1):6456. doi: 10.1038/s41598-023-33484-6.
5
Pre-existing autoimmunity is associated with increased severity of COVID-19: A retrospective cohort study using data from the National COVID Cohort Collaborative (N3C).既往自身免疫与COVID-19病情加重相关：一项使用来自国家COVID队列协作组（N3C）数据的回顾性队列研究。
medRxiv. 2023 Feb 4:2023.02.02.23285353. doi: 10.1101/2023.02.02.23285353.
6
Inflammatory bowel disease and COVID-19 outcomes: a meta-analysis.炎症性肠病与 COVID-19 结局：荟萃分析。
Sci Rep. 2022 Dec 9;12(1):21333. doi: 10.1038/s41598-022-25429-2.
7
Application of Monoclonal Antibody Drugs in Treatment of COVID-19: a Review.单克隆抗体药物在COVID-19治疗中的应用：综述
Bionanoscience. 2022;12(4):1436-1454. doi: 10.1007/s12668-022-00997-9. Epub 2022 Jun 15.
8
Risk factors associated with hospital transfer among mild or asymptomatic COVID-19 patients in isolation facilities in Tokyo: a case-control study.东京隔离设施中轻症或无症状COVID-19患者医院转运的相关危险因素：一项病例对照研究。
IJID Reg. 2022 Mar;2:8-15. doi: 10.1016/j.ijregi.2021.11.001. Epub 2021 Nov 17.
9
Cell deaths: Involvement in the pathogenesis and intervention therapy of COVID-19.细胞死亡：在 COVID-19 发病机制和干预治疗中的作用。
Signal Transduct Target Ther. 2022 Jun 13;7(1):186. doi: 10.1038/s41392-022-01043-6.
10
Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry.全国性COVID-19-EII研究：西班牙炎症性肠病和COVID-19患者登记处（ENEIDA）的发病率、环境风险因素及长期随访
J Clin Med. 2022 Jan 14;11(2):421. doi: 10.3390/jcm11020421.
本文引用的文献
1
Prolonged presence of SARS-CoV-2 viral RNA in faecal samples.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）病毒RNA在粪便样本中的长期存在。
Lancet Gastroenterol Hepatol. 2020 May;5(5):434-435. doi: 10.1016/S2468-1253(20)30083-2. Epub 2020 Mar 20.
2
Implications of COVID-19 for patients with pre-existing digestive diseases.2019冠状病毒病对患有既往消化系统疾病患者的影响。
Lancet Gastroenterol Hepatol. 2020 May;5(5):425-427. doi: 10.1016/S2468-1253(20)30076-5. Epub 2020 Mar 11.
3
Relevant Infections in Inflammatory Bowel Disease, and Their Relationship With Immunosuppressive Therapy and Their Effects on Disease Mortality.炎症性肠病相关感染及其与免疫抑制治疗的关系，以及它们对疾病死亡率的影响。
J Crohns Colitis. 2019 Jul 25;13(7):828-837. doi: 10.1093/ecco-jcc/jjz013.
4
Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases.炎症性肠病治疗相关的严重和机会性感染风险。
Gastroenterology. 2018 Aug;155(2):337-346.e10. doi: 10.1053/j.gastro.2018.04.012. Epub 2018 Apr 12.
5
Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.研究电子数据采集（REDCap）——一种用于提供转化研究信息学支持的元数据驱动方法和工作流程。
J Biomed Inform. 2009 Apr;42(2):377-81. doi: 10.1016/j.jbi.2008.08.010. Epub 2008 Sep 30.
Zotero 插件